|
 |
| home > directory > Progeny Software, LLC |
|
|
 PHARMACEUTICAL INDUSTRY DIRECTORY |
Progeny Software, LLC |
 |
|
| Since 1996, Progeny Software has provided genetic data management solutions to research institutions and clinical genetic services worldwide. From academic labs to global pharmaceutical giants, whether you’re doing family-based or whole genome association studies – Progeny is the ideal solution. Progeny offers 3 products, and any or all products can be securely integrated into a single application:
Progeny LIMS
Complete sample inventory system with barcoding capability, custom workflows, user-based security, wireless handheld devices, and complete chain of custody for all your samples
Progeny Lab
Genotype Data Management - Manage Billions of SNP/STR genotypes from your genotyping platform of choice (Illumina, Affymetrix, and all others) and combine this for WGA, LINKAGE analysis, and/or Fine-Mapping
Progeny Clinical
Pedigree and Clinical Data Management for family-based or population studies.
All products come with a fully customizable, centralized database that allows for multiple users to collaborate while maintaining security. You can custom design the database to include as many fields as you want, design data entry screens, enable security features to restrict access for specific users, run queries over the data, generate custom reports and more.
A free trial download, video demonstrations and much more is available on our website at www.progenygenetics.com. |
|
|
|
|
|
 |
|
|
|
 |
Industry Events |
 |
4th Annual Patient Recruitment and Retention in Clinical Trials
13-15 October 2008, Amsterdam
Patient recruitment
is now consuming thirty percent of clinical trial time - more time than any
other clinical trial activity - and almost half of all trial delays result from
patient recruitment problems.
As the
recruiting culture becomes more sophisticated and the forces affecting patient
enrollment grow more numerous and complex, pharmaceutical companies are
striving to discover new strategies to facilitate enrollment in clinical
trials.
With
increasing industry pressure to develop, test and market greater numbers of new
drugs faster, pharmaceutical companies need to perform clinical trials as
quickly as possible. Inefficient patient recruitment processes is a formidable
barrier to pharmaceutical companies' success in launching new products.
Improving the patient recruitment process is imperative to avoid wasted
investments and eliminate costly delays in bringing new drugs to market --
today and even more so in the not-so-distant future. Improved patient
recruitment presents one of the largest opportunities for pharmaceutical
companies to eliminate delays in clinical trials, thereby making it possible to
reduce time to market. With patent time limits and large overheads
meaning that any delays in the development timeline can be disastrous, a good
understanding of how to successfully recruit patients for trials is vital for
any company looking to succeed.
More info >> |
|
 |
News and Press Releases |
 |
Dr James Thomson to lead new Stem Cell and Regenerative Medicine Center within the new Morgridge Center for Discovery on UW-Madison campus
By
Tom Still
MADISON – There’s no one alive today who was around to witness the birth of
Wisconsin’s
dairy and cranberry industries in the late 1800s, or its rise as a
manufacturing power in roughly the same era. But a new page in Wisconsin’s history of
commerce is being written in our time – the emergence of stem-cell medicine.
Recent events have solidified Wisconsin’s edge as a
global leader in stem-cell research and the breakthroughs in human health it
will produce (continued):
More info >> |
|
 |
|
